Matt Walker, a geneticist and lifelong dog enthusiast, has found a way to enjoy the company of dogs after years of suffering from severe allergies. With the help of a revolutionary gene-editing technique, he can now bond with Bailey, a hypoallergenic beagle, without experiencing the sneezing and rashes that previously plagued him.

Read More

The transformation is attributed to the absence of a specific allergy-causing protein in Bailey's saliva and fur. Walker, who leads Kindred Companion Sciences, developed Bailey and her twin, Alfie, using CRISPR technology. "The feeling right now is sort of a mix of relief and awe and gratitude that it worked," he stated.

While this breakthrough can bring hope to millions of dog allergy sufferers, experts warn that it will take years for such hypoallergenic pets to become widely available. Long-term health effects of the genetic modification must be monitored and effective, affordable methods of commercialization need to be developed. Bioethicist Arthur Caplan from New York University highlighted potential ethical issues, suggesting that this innovation might dissuade individuals from adopting stray or unwanted animals that are not genetically modified.

Previous efforts to create hypoallergenic pets, primarily through cloning, often resulted in health complications due to a lack of genetic diversity. Two years prior, scientists used CRISPR to reduce allergy-causing proteins in a cat named Alsik, though the safety of this technique for wider feline application remains unverified. The common belief that breeds like poodles are hypoallergenic is also misleading, as they still produce proteins that can trigger allergies.

To create Bailey and Alfie, researchers edited the genetic code of dog skin cells to deactivate the main gene responsible for the production of allergy-inducing proteins. This modified code was then transferred into eggs, which were implanted into a surrogate beagle, resulting in the birth of two healthy female puppies in September 2024. Tests confirmed the absence of the targeted protein in their saliva and fur. In an allergy test performed on Walker, his skin reacted to samples from a poodle and a goldendoodle, but showed no reaction to samples from Bailey and Alfie. This research, published in the CRISPR Journal, marks the first successful use of this technique in dogs.

Walker noted that the same allergy-causing gene edited in Alfie and Bailey is present in all dogs. Kindred Companion Sciences plans to expand its research to other breeds and service animals with the aim of developing allergy-free options beyond beagles. However, Dr. Jeff SoRelle, a pathologist at the University of Texas Southwestern Medical Center, emphasized the need for further testing across a broader population of allergy sufferers to gauge the technique's effectiveness. He cautioned that while the edited gene is a major source of allergens, it is not the only one, indicating uncertainty about the overall efficacy of this approach.

Bailey has been living with Walker in New York for over a year, becoming an essential part of his life. Despite Walker's lifelong love for dogs, his allergies had previously prevented him from owning one. Now, he can enjoy having a dog for the first time, engaging in simple activities like tug-of-war and finding comfort in Bailey's presence during difficult times. "It feels just amazing to get to have a dog," he expressed.